Viewing StudyNCT05722912



Ignite Creation Date: 2024-05-06 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722912
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2023-02-10
First Post: 2022-10-04

Brief Title: Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Sponsor: Incyte Corporation
Organization: Incyte Corporation

Conditions & Keywords Data

Conditions:
Name
Graft-versus-host Disease GVHD
Keywords:
Name View
ruxolitinib View
acute or chronic steroid-refractory GVHD View
hematopoietic stem cell transplantation allo-HSCT View